All In Biotech

Drug Trial Radar · NCT06030804

Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery

Impact of Perioperative Dexmedetomidine on Long-term Survival in Older Patients After Cancer Surgery: a Multicenter Randomized Trial

Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 4,532 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

4,532

Planned (sponsor's estimate)

Start

Sep 12, 2023

Primary completion

Sep 2027

Study completion Oct 2030

Sponsor

Lead sponsor
Peking University First HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Peking University
First posted
Sep 11, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Along with aging population, cancer incidence and mortality are increasing. However, despite advances in oncology and surgery, long-term survival of cancer patients is far from optimal. Dexmedetomidine is a highly selective alpha 2 adrenergic receptor agonist with sedative, analgesic, and anxiolytic effects. Studies showed that perioperative use of dexmedetomidine reduces delirium and some non-delirium complications after surgery. In long-term follow-up studies of older patients who, for other reasons, were randomized to receive either dexmedetomidine or placebo during intra- or postoperative period, dexmedetomidine use was associated with improved long-term survival. This multicenter randomized trial aims to investigate the effect of perioperative dexmedetomidine on long-term outcomes in older patients undergoing cancer surgery.

Conditions

  • Elderly
  • Cancer Surgery
  • Dexmedetomidine
  • Long-Term Survivors

Interventions

  • DexmedetomidineDrug

    A loading dose of dexmedetomidine (0.6 μg/kg) will be administered over 10-15 minutes before anaesthesia induction, followed by a continuous infusion at a rate of 0.5 μg/kg/hr till 1 hour before the end of surgery. Patient-controlled dexmedetomidine supplemented sufentanil analgesia will be provided after surgery: the formula contains a mixture of sufentanil (1.25 μg/ml) and dexmedetomidine (1.25 μg/ml), diluted with normal saline to a total volume of 160 ml; the analgesic pump is set to administer a background infusion at a rate of 1 ml/h, with patient-controlled bolus of 2 ml each time and a lockout time of 8 minutes.

  • PlaceboDrug

    Volume-matched normal saline will be administered in the same rate and volume for the same duration as in the dexmedetomidine group during anesthesia. Patient-controlled sufentanil analgesia will be provided after surgery: the formula contains sufentanil (1.25 μg/ml), diluted with normal saline to a total volume of 160 ml; the analgesic pump is set to administer a background infusion at a rate of 1 ml/h, with patient-controlled bolus of 2 ml each time and a lockout time of 8 minutes.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free survival after surgeryTime frame: Up to 3 years after surgery of the last enrolled patient.

Locations

40 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of China University of Science and Technology

    Hefei, Anhui, China · Recruiting

  • The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)

    Hefei, Anhui, China · Recruiting

  • Peking University First Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Tsinghua University Yuquan Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Cancer Hospital Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, China · Recruiting

  • The First Affiliated Hospital of Army Medical University (Southwest Hospital)

    Chongqing, Chongqing Municipality, China · Recruiting

  • Fujian Provincial Hospital

    Fuzhou, Fujian, China · Recruiting

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, China · Recruiting

  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, China · Not yet recruiting

  • Jinjiang City Hospital (Shanghai Sixth People's Hospital, Fujian Hospital)

    Jinjiang, Fujian, China · Recruiting

  • Guangdong General Hospital

    Guangzhou, Guangdong, China · Recruiting

  • Peking University Shenzhen Hospital

    Shenzhen, Guangdong, China · Recruiting

  • The First Affiliated Hospital of Shenzhen University

    Shenzhen, Guangdong, China · Recruiting

  • The Second Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Recruiting

  • Affiliated Cancer Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Recruiting

  • Zhejiang Cancer Hospital

    Zhejiang, Hangzhou, China · Not yet recruiting

  • The Fourth Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China · Recruiting

  • Tangshan Workers' Hospital

    Tangshan, Hebei, China · Not yet recruiting

  • The Second Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, China · Recruiting

  • Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang, China · Recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Recruiting

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, China · Recruiting

  • Xiangya Hospital Central South university

    Changsha, Hunan, China · Recruiting

  • The First Affiliated Hospital of University of South China

    Hengyang, Hunan, China · Not yet recruiting

  • Nanjing General Hospital of Nanjing Military Region

    Nanjing, Jiangsu, China · Recruiting

  • Affiliated Drum Tower Hospital, Medical School of Nanjing University

    Nanjing, Jiangsu, China · Recruiting

  • The Second Affiliated Hospital of Suzhou University

    Suzhou, Jiangsu, China · Recruiting

  • Bethune First Hospital Of Jilin University

    Changchun, Jilin, China · Recruiting

  • General hospital of eastern theater command

    Nanjing, Nanjing, China · Not yet recruiting

  • General Hospital of Ningxia Medical University

    Yinchuan, Ningxia, China · Not yet recruiting

  • People's Hospital of Ningxia Hui Autonomous Region

    Yinchuan, Ningxia, China · Recruiting

  • Xijing Hospital, Fourth Military Medical University

    Xi'an, Shaanxi, China · Recruiting

  • Shandong Provincial Hospital Heze Hospital

    Heze, Shandong, China · Recruiting

  • Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

  • Shanxi Cancer Hospital

    Taiyuan, Shanxi, China · Recruiting

  • Shanxi Provincial People's Hospital

    Taiyuan, Shanxi, China · Recruiting

  • Shanxi Bethune Hospital

    Taiyuan, Shanxi, China · Recruiting

  • Shanxi Bethune Hospital

    Taiyuan, Shanxi, China · Recruiting

  • First Affiliated Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang, China · Recruiting

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.